Skip to main content
. 2020 Feb 21;5:19. doi: 10.1038/s41392-020-0120-3

Fig. 1.

Fig. 1

Colorectal cancer cells downregulate DNA repair pathways (MMR and HR) and upregulate error-prone DNA polymerases in response to targeted therapies, thereby promoting adaptive mutability and microsatellite instability (MSI)